The generic market of ‘celecoxib’ is heated up along with approvals of 45 products only in this year
The arthritis treatment ‘celecoxib’ generic market has attracted the industry.
According to the Ministry of Food and Drug Safety, 103 generic products of ‘celecoxib,’ whose patent will be expired on the coming 11th of June, has been approved as of the 29th of April.
Especially, 45 products were...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
